Skip to main content

Table 2 Patients characteristics

From: Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior

   Patients (n) Percentage
Sex Men 43 48.9%
Women 45 51.1%
Age (years) Mean (min-max) 70.9 (25–93)
RIN Mean (min-max) 8.9 (7.5-10)
Duke's Stage A 24 27.27%
B 26 29.55%
C 19 21.59%
D 19 21.59%
MSS/MSI MSS 79 89.8%
MSI 9 10.2%
Location Ascending C. 33 37.5%
Sigmoid 32 36.4%
Rectum 14 15.9%
Descending C. 3 3.4%
  Transverse C. 6 6.8%
Mut. PI3K Exon 9 12 13.6%
Exon 20 8 9.1%
Wild Type 68 77.3%
Mut. B-Raf Mutated 8 9.1%
Wild Type 80 90.9%
Mut. K-ras Codon 12 28 31.8%
Codon 13 6 6.8%
Wild Type 54 61.4%
Histologic grade Undifferentiated 1 1.1%
  Poorly diff. 5 5.7%
  Moderately diff. 51 58.0%
  Well diff. 31 35.2%
Histologic subtypes Conventional 78 88.64%
  Mucinous 10 11.36%
Tumoral margin Expansive 16 18.18%
  Infiltrative 61 69.32%
  Mixed 11 12.50%
Vascular invasion Yes 33 37.50%
  No 55 62.50%
Perineural invasion Yes 8 9.09%
  No 80 90.91%
Lymphocyte infiltration Absent 53 60.23%
  Low 15 17.05%
Medium 17 19.32%
  High 3 3.41%
  1. RIN: RNA integrity factor.